






• 50 PCI patients and 50 CABG patients were randomly 
selected
• 1 patient was excluded due to intolerance to statins
• Patients were identified using ICD10 coding for CABG or 
PCI
• Patients were analyzed through retrospective chart review 
utilizing computerized physician order entry and medical 
records to gather data on statin selection and doses from 
April 2016 to August 2016
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• The results of this study reflect gaps in the implementation of 
guideline recommended therapy with high intensity statins (<75 
years old). In analyzing the primary endpoint, only 67% of patients 
in the PCI group and 60% of patients in the CABG group received 
appropriate statin doses at discharge. 
• In analyzing the secondary endpoint, 76% of patients in the PCI 
group and 59% of patients in the CABG group received 
appropriate statin doses post-procedure.
• An incidental finding of this review revealed that 82% of PCI and 
CABG patients were discharged on the same statin that they were 
admitted with, regardless of the appropriateness.  
• Physician education on high intensity statin selection and 
identifying areas of improvement in medication reconciliation 
processes at discharge may prove to optimize appropriate statin 
prescribing. 
• Currently GMC uses order sets for patients undergoing PCI or 
CABG procedures. The data from this review will be presented to 
the respective cardiovascular groups for revision of these order 
sets to promote high intensity statin selection.
 24% of patients did not receive the appropriate 
statin post-procedure 
 33% of patients did not receive the appropriate 
statin at discharge 
 41% of patients did not receive appropriate 
statin post-procedure 
40% of patients did not receive appropriate 
statin at discharge 
A B C












PCI 7% 21% 22%
CABG 24% 38% 27%
61%
American College of Cardiology/American Heart Association 
(ACC/AHA) guidelines for cholesterol and acute coronary 
syndrome (ACS) recommend high intensity statins for 
secondary prevention in high-risk coronary artery disease 
patients as they have been proven to significantly reduce 
recurrence of cardiovascular events3. Analyses and reports 
have shown that major gaps still remain in implementing high-
intensity statins in these patients, despite strong guideline 
recommendations1,2. 
A retrospective analysis published in the Journal of American 
College of Cardiology evaluated high intensity statin use post-
discharge in patients hospitalized for acute myocardial 
infarction or revascularization2:
• Only 27% of patients had post-discharge, 1st fills for high 
intensity statins, as recommended by ACC/AHA 
guidelines
• Approximately 23% who were not on a statin previously 
had prescriptions filled for high intensity statins post 
discharge
• Only 9.4% of those who were on low/moderate intensity 
statins had prescriptions filled for high intensity statins 
post discharge
PURPOSE
Based on the above analysis and observations in prescribing 
practices, we decided to conduct this study to evaluate the gaps 
in statin prescribing in post-percutaneous coronary intervention 
(PCI) and coronary artery bypass graft (CABG) patients at 
Gwinnett Medical Center (GMC) a 500 bed community hospital.  
• Primary endpoint: % of patients discharged on high 
intensity statins or moderate intensity, if >75 years old
• Secondary endpoint: % of patients who received high-
intensity statins post-surgery or moderate, if >75 years old 
 Patient Demographics: Majority of patients were males over the age of 55 
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